[1]
Rakshit, G. and Jayaprakash, V. 2022. #51 Design, development, and evaluation of pyrazoline based mycobactin analogues as anti-tubercular agents: An in-silico approach. Journal of Pharmaceutical Chemistry. 8, Supplement (Jul. 2022).